penny stock of NWBO august 7 2012

penny stock of NWBO august 7 2012 : Shares of Northwest Biotherapeutics Inc. (PINK: NWBO), a development stage biotechnology company engaged in the discovery, development and commercialization of immunotherapy products that generate and improve immune system responses to treat cancers in the U.S., rose sharply in Monday’s trading session.

The penny stock of NWBO ended the day 2.99% higher at $0.448, with volume up from daily average of 513,183 to 11.06 million. Despite Monday’s gains, NWBO has fallen more than 8% in the last three trading sessions.

According to a recent filing made by Northwest Biotherapeutics, the company had an operating loss of $5.765 million for the three-month period ended March 31, 2012, compared to an operating loss of $4.64 million reported for the three-month period ended December 31, 2011. The company had a net loss of $10.151 million for the three-month period ended March 31, 2012, compared to a net loss of $12.57 million reported for the three-month period ended December 31, 2011.

For the latest updates on the stock market, PRESS CTR + D or visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post: